GMP inspection history: No 483; Zero recall

GMP inspection and approval:

2007: CFDA (China) 2009: MHRA (UK Food and Drug Administration)

2012: CFDA (National Food and Drug Administration) (China), COFEPRIS (Federal Commission for the Defense of Health Risks in Mexico)

2013: BGV (Germany), FDA (US Food and Drug Administration)

2014: COFEPRIS (Federal Commission for the Defense of Health Risks in Mexico)

2016: BGV (Germany)

2017: WHO (World Health Organization) (Geneva)

2018: FDA (US Food and Drug Administration): WHO (World Health Organization) (Geneva); BGV (Germany)

2019: FDA (US Food and Drug Administration); NMPA (China), WHO (World Health Organization) (Geneva)

2020: NMPA (National Medical Products Administration) (China)

2021: NMPA (National Medical Products Administration) (China)

2023: FDA (Food and Drug Administration); KFDA (Korea Food and Drug Administration)

2025: FDA (Food and Drug Administration); ANVISA (Brazilian National Health Regulatory Agency)